Inheritance of mitochondrial disorders

被引:20
作者
Chinnery, PF [1 ]
机构
[1] Med Sch Newcastle Upon Tyne, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
mitochondrial DNA; mitochondrial genetics; mitochondrial encephalomyopathy; heteroplasmy; segregation;
D O I
10.1016/S1567-7249(02)00046-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Over the last decade there have been major advances in our understanding of the genetic basis of mitochondrial disease, enabling genetic counseling for patients with autosomal dominant and autosomal recessive disorders. Genetic counseling for patients with mitochondrial DNA (mtDNA) mutations is less well established. Approximately one-third of adults with a mtDNA disorder are sporadic cases, usually due to a single deletion of mtDNA. About two-thirds of adults with mtDNA disease harbor a maternally transmitted point mutation. The recurrence risks are well documented for homoplasmic mtDNA mutations causing Leber hereditary optic neuropathy, but the situation is less clear for families with heteroplasmic mtDNA disorders. Two large studies have shown that for some heteroplasmic point mutations there appears to be a relationship between the percentage level of mutant mtDNA in a mother's blood and her risk of having clinically affected offspring. The situation is less clear for other point mutations, some of which may cause sporadic disease. Recent evidence has cast light on the general principles behind the transmission of heteroplasmic mtDNA point mutations, which may be important for genetic counseling in the future. Crown Copyright (C) 2002 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:149 / 155
页数:7
相关论文
共 56 条
[31]   Pedigree analysis of French Canadian families with T14484C Leber's hereditary optic neuropathy [J].
Macmillan, C ;
Kirkham, T ;
Fu, K ;
Allison, V ;
Andermann, E ;
Chitayat, D ;
Fortier, D ;
Gans, M ;
Hare, H ;
Quercia, N ;
Zackon, D ;
Shoubridge, EA .
NEUROLOGY, 1998, 50 (02) :417-422
[32]   Leber hereditary optic neuropathy [J].
Man, PYW ;
Turnbull, DM ;
Chinnery, PF .
JOURNAL OF MEDICAL GENETICS, 2002, 39 (03) :162-169
[33]   The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA [J].
Mandel, H ;
Szargel, R ;
Labay, V ;
Elpeleg, O ;
Saada, A ;
Shalata, A ;
Anbinder, Y ;
Berkowitz, D ;
Hartman, C ;
Barak, M ;
Eriksson, S ;
Cohen, N .
NATURE GENETICS, 2001, 29 (03) :337-341
[34]   Association of myopathy with large-scale mitochondrial DNA duplications and deletions: Which is pathogenic? [J].
Manfredi, G ;
Vu, T ;
Bonilla, E ;
Schon, EA ;
DiMauro, S ;
Arnaudo, E ;
Zhang, L ;
Rowland, LP ;
Hirano, M .
ANNALS OF NEUROLOGY, 1997, 42 (02) :180-188
[35]   Evidence from human oocytes for a genetic bottleneck in an mtDNA disease [J].
Marchington, DR ;
Macaulay, V ;
Hartshorne, GM ;
Barlow, D ;
Poulton, J .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (03) :769-775
[36]   Clinical spectrum and diagnosis of mitochondrial disorders [J].
Munnich, A ;
Rustin, P .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 106 (01) :4-17
[37]   Familial cerebellar ataxia with muscle coenzyme Q10 deficiency [J].
Musumeci, O ;
Naini, A ;
Slonim, AE ;
Skavin, N ;
Hadjigeorgiou, GL ;
Krawiecki, N ;
Weissman, BM ;
Tsao, CY ;
Mendell, JR ;
Shanske, S ;
De Vivo, DC ;
Hirano, M ;
DiMauro, S .
NEUROLOGY, 2001, 56 (07) :849-855
[38]   Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder [J].
Nishino, I ;
Spinazzola, A ;
Hirano, M .
SCIENCE, 1999, 283 (5402) :689-692
[39]  
Papadopoulou LC, 1999, NAT GENET, V23, P333